BHR Pharma, LLC

15 Mount Kemble Ave Ste 1, Morristown, New Jersey, United States

Clinical Trials

11 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

25.0%

Phase 1

18.8%

Phase 2

6.3%

Trial Status Distribution

Active, not recruiting

68.8%

Completed

12.5%

Terminated

18.8%

Clinical Trials

Trials sponsored by this organization (16)

A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women with BI-RADS Breast Density Categories C or D

Phase 1

Active, not recruiting

Nov 2017330 participants

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Phase 3

Terminated

interventional

Aug 2017223 participants

Study of Progesterone in Treatment of Vasomotor Symptoms

Phase 3

Terminated

interventional

Aug 201755 participants

Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

Phase 2

Terminated

interventional

Jul 201534 participants

The study is designed to determine the safety and efficacy of Progesterone in patients with severe head injury

Active, not recruiting

Feb 20121,180 participants

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients with Severe Traumatic Brain Injury - ND

Active, not recruiting

Nov 20101,180 participants

Estudio en Fase III, aleatorizado, doble ciego, controlado con placebo para investigar la eficacia y seguridad de Progesterona en pacientes con Traumatismo Craneoencefálico Severo

Active, not recruiting

Jul 20101,180 participants

The study is designed to determine the safety and efficacy of Progesterone in patients with severe head injury

Active, not recruiting

Jul 20101,180 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations